Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase II study of trastuzumab + cisplatin + gemcitabine in HER2-positive advanced cholangiocarcinoma
TCTR20220328005Phase 2Recruiting
- Sponsor
- Khon Kaen University
- Start
- Mar 2022
- Modality
- Monoclonal Antibodies → Antibody-Based Therapeutics
- Countries
- 1
01
Overview
A Phase 2 trial of trastuzumab in cholangiocarcinoma (CCA), sponsored by Khon Kaen University. Started Mar 2022; status: recruiting.
02
Drugs
03
Conditions
cholangiocarcinoma (CCA)
Beyond the preview
Go deeper on TCTR20220328005.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on TCTR20220328005.